Also, the Kitasato Institute fertilized egg process has become Adimmune's mainstay, allowing it to corner a domestic market of around NT $ 150 million annually.
另一方面，北里的雞胚胎蛋疫苗製程更是國光的主力，幾乎是獨占每年大約 1.5 億台幣的內需市場。